19

Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer. Scandinavian Prostatic Cancer Group (SPCG) Study No. 5.

Hedlund PO, Ala-Opas M, Brekkan E, Damber JE, Damber L, Hagerman I, Haukaas S, Henriksson P, Iversen P, Pousette Å, Rasmussen F, Salo J, Vaage S, Varenhorst E and the SPCG-5 Study Group

Scand J Urol Nephrol. 2002

SPCG-5

Abstract

18

Sexual function: quality of life issues in patients with locally advanced non-metastatic prostate cancer.

Iversen P, Newling D, Kirby R, Eadrley I.

Eur Urol Suppl 2002

Abstract

17

Immediate therapy in early prostate cancer: Results from the bicalutamide (Casodex) EPC Programme.

Wirth M, Iversen P, Mcleod D, See W.

Eur Urol Suppl 2002

Abstract

16

Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate

Spetz A-C, Hammar M, Lindberg B, Spångberg A, Varenhorst E and the Scandinavian Prostatic Cancer Group-5 Trial Study

J Urol. 2001

SPCG-5

Abstract

15

The bicalutamide Early Prostate Cancer Program. Demography

See W, McLeod D, Iversen P, Wirth M

Urol Oncol. 2001

SPCG-6

Abstract

14

Parenteral Estrogen versus Total Androgen Ablation in the Treatment of Advanced Prostate Carcinoma: Effects on Overall Survival and Cardiovascular Mortality

Hedlund PO, Henriksson P

Urology. 2000

SPCG-5

Abstract

13

Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2

Jørgensen T, Kanagasingam Y, Kaalhus O, Tveter KJ, Bryne M, Skjørten F, Berner A, Danielsen HE

J Urol. 1997

SPCG-2

Abstract

12

Combined Androgen Blockade in the Treatment of Advanced Prostatic Cancer – An overview.

Iversen, P. on behalf of the Scandinavian Prostatic Cancer Group.

Scand J Urol Nephrol. 1997

Abstract

11

Treatment of High-grade, High-stage Prostate Cancer with Estramustine Phosphate or Diethylstilbestrol

Hedlund PO, Jacobsen H, Vaage S, Hahne B, Sandin T, Kontturi M, Nordle Ö, Esposti P and the SPCG-1-Study Group

Scand J Urol Nephrol. 1997

SPCG-1

Abstract

10

The Scandinavian Prostatic Cancer Group. Editorial.

Hedlund PO and the SPCG Group.

Scand J Urol Nephrol. 1997

Abstract